Covered recipient · General Payments record
JAKNEL BROWN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2021–2024
$1,130.12
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $454.23 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $119.02 | 5 |
| JAZZ PHARMACEUTICALS INC. | $72.59 | 2 |
| SK Life Science, Inc. | $67.37 | 3 |
| Neurelis, Inc. | $57.20 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $42.61 | 2 |
| Amgen Inc. | $27.67 | 1 |
| Metacel Pharmaceuticals LLC | $24.28 | 1 |
| AQUESTIVE THERAPEUTICS, INC. | $23.63 | 1 |
| NS Pharma, Inc. | $19.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $27.67 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117515435 | CMS |
| AQUESTIVE THERAPEUTICS, INC. | $23.63 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146436957 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $18.55 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144450586 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $24.06 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144450588 | CMS |
| JAZZ PHARMACEUTICALS INC. | $34.92 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150203230 | CMS |
| JAZZ PHARMACEUTICALS INC. | $37.67 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150203228 | CMS |
| Metacel Pharmaceuticals LLC | $24.28 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099648343 | CMS |
| Neurelis, Inc. | $28.24 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145635373 | CMS |
| Neurelis, Inc. | $28.96 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145635378 | CMS |
| NS Pharma, Inc. | $19.86 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139459180 | CMS |
| SK Life Science, Inc. | $24.15 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154130437 | CMS |
| SK Life Science, Inc. | $16.44 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154130451 | CMS |
| SK Life Science, Inc. | $26.78 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154130463 | CMS |
| UCB, Inc. | $25.11 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033733 | CMS |
| UCB, Inc. | $30.66 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033735 | CMS |
| UCB, Inc. | $28.46 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033737 | CMS |
| UCB, Inc. | $13.78 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033739 | CMS |
| UCB, Inc. | $21.01 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033741 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.